{
    "clinical_study": {
        "@rank": "152945", 
        "acronym": "BABY HUG", 
        "arm_group": [
            {
                "arm_group_label": "Active", 
                "description": "Blood and urine specimens, and questionnaires related to the child's health status.\nLiver Spleen Scan\nAbdominal Ultrasound\nBrain MRI/MRA\nCardiac Echocardiogram/Pulmonary Function Testing\nTranscranial Doppler\nNeuropsychology Testing (Vineland, WISC-IV, Connor CPT II and Peds QOL)"
            }, 
            {
                "arm_group_label": "Passive", 
                "description": "Information from usual clinical care of sickle cell disease. We will collect information from routine tests ordered by the child's clinical sickle cell doctors."
            }
        ], 
        "biospec_descr": {
            "textblock": "Stored blood and urine"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The BABY HUG Treatment Study was designed to see if treatment with the drug hydroxyurea\n      (also called HU) in children with sickle cell disease could prevent organ damage, especially\n      in the spleen and kidneys.  There was also a chance that treatment could prevent painful\n      crises, lung disease, stroke, and blood infection."
        }, 
        "brief_title": "Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Sickle Cell Anemia", 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Anemia, Sickle Cell"
            ]
        }, 
        "detailed_description": {
            "textblock": "The current observational trial, Follow-Up Study II (designated FUS II) includes enhanced\n      neuropsychological, brain, cardiac, and pulmonary evaluations for this very well\n      characterized cohort of subjects. Measures of spleen and renal function and markers of DNA\n      damage will continue to be collected. Assessment of other target organs in sickle cell\n      disease including pulmonary and cardiac function will be performed in addition to evaluation\n      of developmental aspects of SCD and potential HU toxicity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All subjects enrolled in the BABY HUG Follow-Up I Study who participated for at least\n             24 months are eligible for the Follow-Up Study II\n\n        Exclusion Criteria:\n\n          -  Subjects that have received a Stem Cell Transplant are not eligible for enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "24 Months", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "All subjects enrolled in the BABY HUG Follow-Up I Study who participated for at least 24\n        months are eligible for the Follow-Up Study II."
            }
        }, 
        "enrollment": {
            "#text": "158", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783990", 
            "org_study_id": "HHSN268201200023C"
        }, 
        "intervention": {
            "arm_group_label": [
                "Active", 
                "Passive"
            ], 
            "description": "Active and Passive groups both are on HU.", 
            "intervention_name": "Hydroxyurea", 
            "intervention_type": "Drug", 
            "other_name": "HU"
        }, 
        "intervention_browse": {
            "mesh_term": "Hydroxyurea"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 4, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20060"
                    }, 
                    "name": "Howard University College of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }, 
                    "name": "Children's National Medical Center Center for Cancer and Blood Disorders"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University of Miami School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "Emory University School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }, 
                    "name": "Johns Hopkins University School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21215"
                    }, 
                    "name": "Sinai Hospital of Baltimore Alfred I Coplan Pediatric Hematology Oncology Outpatient Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Children's Hospital of Michigan/Wayne State University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39216"
                    }, 
                    "name": "University of Mississippi Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "Downstate Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Medical University of South Carolina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38105"
                    }, 
                    "name": "St. Jude Children's Research Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "University of Texas Southwestern Medical Center at Dallas"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol", 
        "overall_official": {
            "affiliation": "Clinical Trials and Surveys", 
            "last_name": "Bruce Thompson, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety of HU will be assessed by ongoing clinical monitoring of growth and development, age-appropriate neuropsychological evaluation, serial hematologic and chemistry parameters, and the frequency of expected and unexpected clinical events related to sickle cell disease.  Disease and treatment-related effects on the spleen will be measured by a liver-spleen scan, pitted cell counts and HJB enumeration. Kidney function will be measured by GFR estimation from the Schwartz formula or cystatin C measurements and the urine osmolality and urine microalbumin:creatinine ratio. The BH FU II investigators will also seek to study how early treatment with HU changes the child's disease trajectory on open-label HU.", 
            "measure": "The primary objective of Follow-Up Study II is to monitor the continued safety and potential efficacy of HU treatment.", 
            "safety_issue": "Yes", 
            "time_frame": "Every 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783990"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Heart, Lung, and Blood Institute (NHLBI)", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institutes of Health (NIH)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}